| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/02/2013 | WO2013062024A1 Plant disease control agent containing arylamidine derivative or salt thereof |
| 05/02/2013 | WO2013060818A1 Novel process |
| 05/02/2013 | WO2013060653A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | WO2013036912A3 Amido compounds as rorϒtmodulators and uses thereof |
| 05/02/2013 | US20130109719 Method of treating attention deficit disorders with d-threo methylphenidate |
| 05/02/2013 | US20130109718 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | US20130109701 Chemical Compounds |
| 05/02/2013 | US20130108573 Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| 05/02/2013 | CA2851062A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/01/2013 | EP2585064A1 C5ar antagonists |
| 05/01/2013 | EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |
| 05/01/2013 | CN103080090A Anti-inflammatory agents |
| 05/01/2013 | CN103080089A 5-HT2B receptor antagonists |
| 05/01/2013 | CN103080088A Production method of intermediate compound for synthesizing medicament |
| 05/01/2013 | CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders |
| 05/01/2013 | CN103080086A Prostaglandin D synthase inhibitory piperidine compounds |
| 05/01/2013 | CN103073695A Intrinsic room-temperature self-repairing crystalline polymer |
| 05/01/2013 | CN103073485A Preparation method for clevidipine butyrate |
| 05/01/2013 | CN103073484A Preparation method of mepivacaine and optical enantiomer of mepivacaine |
| 05/01/2013 | CN103073483A Preparation method of mepivacaine and optical enantiomer of mepivacaine |
| 05/01/2013 | CN103073482A Method for extracting DNJ (Deoxynojirimycin) from frosted mulberry leaf by fermenting |
| 05/01/2013 | CN103073476A Synthetic method of N-aryl-5-trifluoromethyl-2-pyrrolidone and N-aryl-6-trifluoromethyl-2-pyridine alkyl ketone |
| 05/01/2013 | CN103073472A Preparation method of 2-trifluoromethyl-1-carbobenzoxy-1-aza-cyclane |
| 05/01/2013 | CN103073440A Diphenylvinyloxy alkylamine compound and preparation method as well as application thereof |
| 05/01/2013 | CN102070514B Method for preparing halofuginone intermediate |
| 05/01/2013 | CN101879444B Preparation and application of stannate solid alkali catalyst |
| 05/01/2013 | CN101723935B 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof |
| 05/01/2013 | CN101528223B New small molecule inhibitors of MDM2 and the uses thereof |
| 04/30/2013 | US8431710 Process for the synthesis of halogenated cyclic compounds |
| 04/30/2013 | US8431709 Acylation reaction of hydroxyl group |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/30/2013 | US8431039 Mesogenic stabilizers |
| 04/30/2013 | CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors |
| 04/25/2013 | WO2013058218A1 (meth)acrylate compound, and photochromic curable composition containing said (meth)acrylate compound |
| 04/25/2013 | WO2013057320A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | WO2012037928A3 Compounds for the diagnosis of neurodegenerative disorders on the olfactory epithelium |
| 04/25/2013 | US20130102779 Substituted Tetracycline Compounds |
| 04/25/2013 | US20130102774 Thionation process and a thionating agent |
| 04/25/2013 | US20130102639 Inhibitors of protein prenyltransferases |
| 04/25/2013 | US20130102626 Targeted nitroxide agents |
| 04/25/2013 | CA2852917A1 Amine cationic lipids and uses thereof |
| 04/25/2013 | CA2852355A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | CA2851998A1 (meth)acrylate compound and photochromic curable composition containing the (meth)acrylate compound |
| 04/24/2013 | EP2582690A1 Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates |
| 04/24/2013 | EP2582671A2 Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride |
| 04/24/2013 | EP2582670A1 Piperidinyl compound as a modulator of chemokine receptor activity |
| 04/24/2013 | EP2582669A1 Process for preparing a cyclic tertiary methylamine |
| 04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 04/24/2013 | CN103068825A Spiroheterocyclical substituted tetramic acid derivatives |
| 04/24/2013 | CN103068800A Piperidinyl compound as a modulator of chemokine receptor activity |
| 04/24/2013 | CN103068799A Benzamide derivatives and their use as hsp90 inhibtors |
| 04/24/2013 | CN103068797A Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 04/24/2013 | CN103068385A C5ar antagonists |
| 04/24/2013 | CN103058990A Benzimidazoles which have activity at m1 receptor and uses thereof in medicine |
| 04/24/2013 | CN103058914A Maleic acid levorotation amlodipine crystal form and preparation method thereof |
| 04/24/2013 | CN102417884B Aspergillus niger strain and application thereof in enrichment and extraction of 1-deoxynojirimycin (1-DNJ) from white mulberry root-bark |
| 04/23/2013 | US8426604 Aminothiazolones as estrogen related receptor-alpha modulators |
| 04/23/2013 | US8426602 Heteroaryl-substituted dicyanopyridines and their use |
| 04/23/2013 | US8426587 Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor |
| 04/23/2013 | US8426431 Substituted 2-aminoacetamides and the use thereof |
| 04/23/2013 | US8426407 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1H)pyridone compounds and salts thereof and their applications |
| 04/23/2013 | CA2624934C Preparing method for amorphous lercanidipine |
| 04/23/2013 | CA2565632C Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/23/2013 | CA2542650C Bridged ring structures as pharmaceutical agents |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096161 Novel Dihydropyridin-2(1H)-One Compounds as S-Nitrosoglutathione Reductase Inhibitors and Neurokinin-3 Receptor Antagonists |
| 04/18/2013 | US20130096105 ArylSulfonamide Based Matrix Metalloprotease Inhibitors |
| 04/18/2013 | US20130095376 Electrode active material for secondary battery and secondary battery |
| 04/17/2013 | EP2581366A1 Renin Inhibitors |
| 04/17/2013 | EP2580197A1 Anti-inflammatory agents |
| 04/17/2013 | EP2580196A1 Anti-inflammatory agents |
| 04/17/2013 | EP2580193A1 Benzamide derivatives and their use as hsp90 inhibtors |
| 04/17/2013 | CN103044317A Method and system for preparing 3-picoline |
| 04/17/2013 | CN103044316A Method for preparing 1,4-dihydropyridine by using imidazole ionic liquid as catalyst |
| 04/17/2013 | CN103044315A Method for preparing 1,4-dihydropyridine by taking acidic ionic liquid as catalyst |
| 04/17/2013 | CN103044314A Preparation method of amlodipine maleate |
| 04/17/2013 | CN102344479B Preparation method of quaternary ammonium salts of methyl ammonium bromide |
| 04/17/2013 | CN102276516B Levamlodipine besylate crystals, preparation method thereof and brand-new medicinal composition containing crystals |
| 04/17/2013 | CN101869844B Novel solid alkali catalyst, preparation and application thereof |
| 04/16/2013 | US8420661 Arylethynyl derivatives |
| 04/16/2013 | US8420637 Abnormal cannabidiols as agents for lowering intraocular pressure |
| 04/16/2013 | CA2643170C Sterically hindered amine ethers as stabilizers against light, oxygen and/or heat |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2484512C Treatment of cataracts and other ophthalmic diseases |
| 04/11/2013 | WO2013050987A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | WO2013050721A1 Compounds that trap alpha-oxoaldehydes and alpha-beta-unsaturated aldehydes, meta-compounds containing such compounds, and use of said compounds in treating illnesses related to the accumulation of ages and ales |
| 04/11/2013 | WO2013006098A3 2,6-diisobornylphenol derivatives |
| 04/11/2013 | US20130090357 Deuterium-enriched donepezil |
| 04/11/2013 | CA2851405A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/10/2013 | EP2578569A1 Heterocyclic ring compound and h1 receptor antagonist |
| 04/10/2013 | EP2576511A1 Spiroheterocyclic pyrrolidine derivatives based pesticides |
| 04/10/2013 | EP2576510A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 04/10/2013 | EP2576509A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies |
| 04/10/2013 | EP2576507A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 04/10/2013 | EP2575449A2 Pesticidal compositions |
| 04/10/2013 | CN103030590A High-quality polymerization inhibitor and preparation technology of same |
| 04/10/2013 | CN103030589A N-(4-fluorobenzyl)-3, 5-bis(4-trifluoromethyl benzylidene)-4-piperodone and preparation as well as application |
| 04/10/2013 | CN103030588A Preparation technology of light stabilizer |
| 04/10/2013 | CN103030587A Synthesis process of 3-methylamino-piperidine |
| 04/10/2013 | CN103030586A Method for preparing rubber or resin multifunctional anti-aging agent |